Tetrabutylammonium iodide-catalyzed synthesis and anticancer screening of 2-thioxoimidazolidine-4,5-dione: a comparative theoretical and experimental approach
Nitin Srivastava , Amit K Chaturvedi , Anant Ram , Poonam Rawat , Ram Kishore , R. N. Singh , Devdutt Chaturvedi
{"title":"Tetrabutylammonium iodide-catalyzed synthesis and anticancer screening of 2-thioxoimidazolidine-4,5-dione: a comparative theoretical and experimental approach","authors":"Nitin Srivastava , Amit K Chaturvedi , Anant Ram , Poonam Rawat , Ram Kishore , R. N. Singh , Devdutt Chaturvedi","doi":"10.1080/17415993.2025.2574910","DOIUrl":null,"url":null,"abstract":"<div><div>Cancer is one of the leading global diseases responsible for morbidity and mortality of humankind. According to the WHO report, one in 5 people worldwide will develop cancer during their lifetime. So, there is a need for the development of new and effective chemotherapeutic drugs. This research reports an optimized, simple, effective, environment-friendly tetrabutylammonium iodide (TBAI) peddled synthetic protocol for 2–thioxoimidazolidine-4,5-diones (<strong>9a-9i</strong>) using readily available, less expensive, and least harmful chemicals at room temperature. The synthesized compounds were further studied for the mechanism of the apoptosis induced in HCT-15 (colon cancer), U87-MG (brain cancer) and HeLa (Cervical cancer) cells based on <em>in-silico</em> and <em>in-vitro</em> approaches. The computational study was conducted at the B3LYP/6-311G (d, p) basis set for analyzing molecular geometry, conformation, stability, and molecular electrostatics potential surface (MEPS). <em>In silico</em> study of the interactions of these compounds (<strong>9a-9i</strong>) and target proteins 5I9B, 6EB5, and 4DK5 of HeLa, HCT-15, and U87-MG, respectively, has been very promising in deactivating the protein synthesis in cancer cells. These compounds may further be developed as effective chemotherapeutics.</div></div>","PeriodicalId":17081,"journal":{"name":"Journal of Sulfur Chemistry","volume":"47 1","pages":"Pages 14-34"},"PeriodicalIF":1.7000,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sulfur Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/org/science/article/pii/S1741599325000522","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer is one of the leading global diseases responsible for morbidity and mortality of humankind. According to the WHO report, one in 5 people worldwide will develop cancer during their lifetime. So, there is a need for the development of new and effective chemotherapeutic drugs. This research reports an optimized, simple, effective, environment-friendly tetrabutylammonium iodide (TBAI) peddled synthetic protocol for 2–thioxoimidazolidine-4,5-diones (9a-9i) using readily available, less expensive, and least harmful chemicals at room temperature. The synthesized compounds were further studied for the mechanism of the apoptosis induced in HCT-15 (colon cancer), U87-MG (brain cancer) and HeLa (Cervical cancer) cells based on in-silico and in-vitro approaches. The computational study was conducted at the B3LYP/6-311G (d, p) basis set for analyzing molecular geometry, conformation, stability, and molecular electrostatics potential surface (MEPS). In silico study of the interactions of these compounds (9a-9i) and target proteins 5I9B, 6EB5, and 4DK5 of HeLa, HCT-15, and U87-MG, respectively, has been very promising in deactivating the protein synthesis in cancer cells. These compounds may further be developed as effective chemotherapeutics.
期刊介绍:
The Journal of Sulfur Chemistry is an international journal for the dissemination of scientific results in the rapidly expanding realm of sulfur chemistry. The journal publishes high quality reviews, full papers and communications in the following areas: organic and inorganic chemistry, industrial chemistry, materials and polymer chemistry, biological chemistry and interdisciplinary studies directly related to sulfur science.
Papers outlining theoretical, physical, mechanistic or synthetic studies pertaining to sulfur chemistry are welcome. Hence the target audience is made up of academic and industrial chemists with peripheral or focused interests in sulfur chemistry. Manuscripts that truly define the aims of the journal include, but are not limited to, those that offer: a) innovative use of sulfur reagents; b) new synthetic approaches to sulfur-containing biomolecules, materials or organic and organometallic compounds; c) theoretical and physical studies that facilitate the understanding of sulfur structure, bonding or reactivity; d) catalytic, selective, synthetically useful or noteworthy transformations of sulfur containing molecules; e) industrial applications of sulfur chemistry; f) unique sulfur atom or molecule involvement in interfacial phenomena; g) descriptions of solid phase or combinatorial methods involving sulfur containing substrates. Submissions pertaining to related atoms such as selenium and tellurium are also welcome. Articles offering routine heterocycle formation through established reactions of sulfur containing substrates are outside the scope of the journal.